Optical genome mapping identifies a homozygous deletion in the non-coding region of the SCN9A gene in individuals from the same family with congenital insensitivity to pain.

SCN9A gene insensitivity to pain non-coding structural variant optical genome mapping structural variant detection

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2024
Historique:
received: 01 02 2024
accepted: 18 07 2024
medline: 19 8 2024
pubmed: 19 8 2024
entrez: 19 8 2024
Statut: epublish

Résumé

We report an index patient with complete insensitivity to pain and a history of painless fractures, joint hypermobility, and behavioral problems. The index patient descends from a family with notable cases among his maternal relatives, including his aunt and his mother's first cousin, both of whom suffer from congenital insensitivity to pain. The patient had normal results for prior genetic testing: fragile-X syndrome testing, chromosomal microarray analysis, and exome sequencing. Optical genome mapping detected a homozygous deletion affecting the noncoding 5' untranslated region (UTR) and the first non-coding exon of the

Identifiants

pubmed: 39156962
doi: 10.3389/fgene.2024.1375770
pii: 1375770
pmc: PMC11327051
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1375770

Informations de copyright

Copyright © 2024 Boughalem, Ciorna-Monferrato, Sloboda, Guegan, Page, Zimmer, Benazra, Kleinfinger, Lohmann, Valduga, Receveur, Martin and Trost.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Aïcha Boughalem (A)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Viorica Ciorna-Monferrato (V)

Génétique Médicale et Oncogénétique, Hôpital Femme Mère Enfant, CHR Metz-Thionville, site de Mercy, 1, Allée du Château, Metz Cedex, France.

Natacha Sloboda (N)

Génétique Médicale et Oncogénétique, Hôpital Femme Mère Enfant, CHR Metz-Thionville, site de Mercy, 1, Allée du Château, Metz Cedex, France.

Amélie Guegan (A)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

François Page (F)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Sophie Zimmer (S)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Marion Benazra (M)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Pascale Kleinfinger (P)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Laurence Lohmann (L)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Mylène Valduga (M)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Aline Receveur (A)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Fernando Martin (F)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Detlef Trost (D)

Department of Human Genetics, Laboratoire CERBA SA, Saint Ouen L'aumône, France.

Classifications MeSH